Your browser doesn't support javascript.
loading
Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: a Nordic population-based cohort study.
Lund Hansen, Rebekka; Schoedt Jørgensen, Tanja; Dreyer, Lene; Hetland, Merete L; Glintborg, Bente; Askling, Johan; Di Giuseppe, Daniela; Jacobsson, Lennart T H; Wallman, Johan K; Nordstrom, Dan; Aaltonen, Kalle; Kristianslund, Eirik K; Kvien, Tore K; Provan, Sella A; Gudbjornsson, Bjorn; Love, Thorvadur J; Kristensen, L E.
Afiliação
  • Lund Hansen R; Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen.
  • Schoedt Jørgensen T; Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen.
  • Dreyer L; Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen.
  • Hetland ML; Department of Rheumatology, Aalborg University Hospital, Aalborg.
  • Glintborg B; DANBIO and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopedics, Rigshospitalet.
  • Askling J; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Di Giuseppe D; DANBIO and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopedics, Rigshospitalet.
  • Jacobsson LTH; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Wallman JK; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm.
  • Nordstrom D; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm.
  • Aaltonen K; Department of Rheumatology & Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg.
  • Kristianslund EK; Department of Clinical Sciences Lund, Rheumatology, Lund University, Skane University Hospital, Lund, Sweden.
  • Kvien TK; ROB-FIN, Division of Medicine, Helsinki University Hospital and Helsinki University.
  • Provan SA; Pharmaceuticals Pricing Board, Ministry of Social Affairs and Health, Helsinki, Finland.
  • Gudbjornsson B; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.
  • Love TJ; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.
  • Kristensen LE; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.
Rheumatology (Oxford) ; 60(1): 140-146, 2021 01 05.
Article em En | MEDLINE | ID: mdl-32591790
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Psoriásica / Antirreumáticos / Medicamentos Biossimilares Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Psoriásica / Antirreumáticos / Medicamentos Biossimilares Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article